文献速递脊柱关节炎

ERAP1与ERAP2基因变异与免疫介导疾病相关并影响蛋白表达及同工型谱

Genetic Variants in ERAP1 and ERAP2 Associated With Immune-Mediated Diseases Influence Protein Expression and the Isoform Profile.
PubMed 文献 · Arthritis Rheumatol · 2017-12-29

研究对染色体5q15区域进行RNA测序和基因分型,检测与ERAP1和ERAP2总基因及同工型特异性表达改变相关的遗传变异,并用质谱验证一个推测的改变mRNA剪接的变异对ERAP-1蛋白水平的功能影响。结果显示,与强直性脊柱炎相关的多态性显著影响ERAP-1和ERAP-2的转录和蛋白表达,风险相关变异与基因表达增加相关,关键ERAP1变异与转录剪接改变及等位基因依赖的两种不同同工型表达相关,并导致产生的ERAP-1蛋白类型显著不同。

要点

  • 与强直性脊柱炎相关的多态性显著影响ERAP-1和ERAP-2的转录和蛋白表达。
  • 两个基因内及周围疾病风险相关多态性也与基因表达增加相关。
  • 关键风险相关ERAP1变异与转录剪接改变相关,导致等位基因依赖的两种不同同工型表达及ERAP-1蛋白类型显著差异。

核心结论

  • 与增加氨肽酶活性易患免疫疾病的研究一致,风险增加也归因于ERAP1和ERAP2表达增加,支持使用氨肽酶抑制治疗强直性脊柱炎和其他ERAP相关疾病的想法。

研究设计与样本

  • 研究对染色体5q15区域进行RNA测序和基因分型,以检测与ERAP1和ERAP2总基因及同工型特异性表达改变相关的遗传变异。
  • 使用质谱验证一个推测的改变信使RNA剪接的变异对ERAP-1蛋白水平的功能影响。

主要发现

  • 与强直性脊柱炎相关的多态性显著影响ERAP-1和ERAP-2的转录和蛋白表达。
  • 两个基因内及周围疾病风险相关多态性也与基因表达增加相关。
  • 关键风险相关ERAP1变异与转录剪接改变相关,导致等位基因依赖的两种不同同工型替代表达及产生的ERAP-1蛋白类型显著差异。

临床怎么用

  • 作者认为,增加氨肽酶活性的多态性易患免疫疾病,风险增加也归因于ERAP1和ERAP2表达增加,支持使用氨肽酶抑制治疗强直性脊柱炎和其他ERAP相关疾病的想法。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Endoplasmic reticulum aminopeptidase 1 (ERAP-1) and ERAP-2, encoded on chromosome 5q15, trim endogenous peptides for HLA-mediated presentation to the immune system. Polymorphisms in ERAP1 and/or ERAP2 are strongly associated with several immune-mediated diseases with specific HLA backgrounds, implicating altered peptide handling and presentation as prerequisites for autoreactivity against an arthritogenic peptide. Given the thorough characterization of disease risk-associated polymorphisms that alter ERAP activity, this study aimed instead to interrogate the expression effect of chromosome 5q15 polymorphisms to determine their effect on ERAP isoform and protein expression. METHODS: RNA sequencing and genotyping across chromosome 5q15 were performed to detect genetic variants in ERAP1 and ERAP2 associated with altered total gene and isoform-specific expression. The functional implication of a putative messenger RNA splice-altering variant on ERAP-1 protein levels was validated using mass spectrometry. RESULTS: Polymorphisms associated with ankylosing spondylitis (AS) significantly influenced the transcript and protein expression of ERAP-1 and ERAP-2. Disease risk-associated polymorphisms in and around both genes were also associated with increased gene expression. Furthermore, key risk-associated ERAP1 variants were associated with altered transcript splicing, leading to allele-dependent alternate expression of 2 distinct isoforms and significant differences in the type of ERAP-1 protein produced. CONCLUSION: In accordance with studies demonstrating that polymorphisms that increase aminopeptidase activity predispose to immune disease, the increased risk also attributed to increased expression of ERAP1 and ERAP2 supports the notion of using aminopeptidase inhibition to treat AS and other ERAP-associated conditions.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Hanson AL, Cuddihy T, Haynes K, et al. Genetic Variants in ERAP1 and ERAP2 Associated With Immune-Mediated Diseases Influence Protein Expression and the Isoform Profile. Arthritis Rheumatol. 2017. PMID: 29108111. doi:10.1002/art.40369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。